Sure, here’s a rewritten version of the content while retaining its original meaning:
<div>
<p class="paragraph" style="text-align: left;">Hello, 360!</p>
<p class="paragraph" style="text-align: left;">Check out some of our biggest movers today.</p>
<p class="paragraph" style="text-align: left;">Don't overlook our MOBILE ALERTS! Many of these alerts have surged 🚀 beyond the MOON 🌝. <span style="background-color: #b8ff97;"><b>Text “RAGE” to 1-(888) 487-1534</b></span><span style="background-color: #b8ff97;"> </span>📲.</p>
<p class="paragraph" style="text-align: left;">Prepare yourself to be the most informed trader on the Street!</p>
<hr class="content_break"/>
<p class="paragraph" style="text-align: center;"><span style="font-size: 1.5rem;"><b>FOCUS LIST</b></span>🔎</p>
<p class="paragraph" style="text-align: left;"><b>NMHI – </b>Increased by more than 140% in pre-market trading after announcing $29.7 million in financing yesterday.</p>
<p class="paragraph" style="text-align: left;"><b>STEM – </b>Rising over 11% in pre-market after revealing plans to support a 484 MW solar portfolio in Hungary, marking the company's largest EMEA software contract.</p>
<p class="paragraph" style="text-align: left;"><b>RGNX – </b>Up over 18% in pre-market following the announcement of an exclusive partnership for developing RGX-121 and RGX-111 for MPS diseases.</p>
<hr class="content_break"/>
<div class="section" style="background-color: #efefef; margin: 0; padding: 0;">
<h5 class="heading" style="text-align: center;"><span style="color: #1d1c1d; font-size: 1.5rem;"><i>Still not with Bullseye Trades?</i></span></h5>
<p class="paragraph" style="text-align: center;"><span style="color: #1d1c1d; font-size: 1.5rem;">You may have missed Jeff’s Pick of the Week: </span><span style="color: #1d1c1d; font-size: 1.5rem;"><b>DJT</b></span></p>
<div class="image">
<p><img decoding="async" class="image__image" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcT6JBP7onwViHefyNiz72y9QpCOYKEzY--OB-00rXsP54mhKB-cUT_pRiOPrMwgBoQHYQRZgGFnXqmORJEGnRKjfCMg48gS_rHJSWt9j06gUklfBsi4q79MXMNtk4WWF_O3N6Z?key=uSlFrBFgOlcjz62zL0ybfQ" alt=""/></p>
<div class="image__source">
<p>*Note: Trading is difficult; results are not guaranteed and should not be expected to be replicated.</p>
</div>
</div>
<p class="paragraph" style="text-align: center;"><span style="color: #1d1c1d; font-size: 1.5rem;">Rockets, baby!</span></p>
<p class="paragraph" style="text-align: center;"><span class="font-size-1.5rem;"><span style="text-decoration: underline;">Be ready for Jeff’s NEXT 52 Rockets [Incoming]</span></span></p>
<p class="paragraph" style="text-align: center;"><span style="color: #1d1c1d; font-size: 1.5rem;">And discover WHY he’s trading in his selected stocks…</span></p>
</div>
<hr class="content_break"/>
<p class="paragraph" style="text-align: center;"><span style="font-size: 1.5rem;"><b>HOTLIST</b></span>🔥</p>
<p class="paragraph" style="text-align: left;"><b>NMHI – Surged over 140% in pre-market, after announcing $29.7 million in financing yesterday.</b></p>
<p class="paragraph" style="text-align: left;">Nature’s Miracle Holding Inc. (<b>NMHI</b>) is an agri-tech firm providing lighting and grow media solutions for controlled environment agriculture in the U.S. and Canada.</p>
<p class="paragraph" style="text-align: left;">In yesterday's pre-market, the company disclosed that it has entered into a Securities Purchase Agreement (“SPA”) with a single institutional investor (“Investor”) effective January 10, 2025. The SPA permits Nature’s Miracle to sell up to $29.7 million in aggregate of a new class of convertible preferred stock to the Investor, subject to standard conditions.</p>
<p class="paragraph" style="text-align: left;">After a 38% drop on low volume yesterday, buying interest has pushed the stock up more than 140% in pre-market trading.</p>
<div class="image"><img decoding="async" class="image__image" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdLBnY8-PBROcvZcFcEQu46ypN5VpbsKg-L1vxMke2_mIb4A6fLZhHtZSQ_0N44UtzYv5rLpSqJVZUK3-ZkruEvSCBqhw7mPxeCNFrB_VDclRK3GeL1oBM-o1N5JCcb3AXBR83Iqw?key=b78cVTfpYS4IEGNeHPhO1T7s" alt=""/></div>
<p class="paragraph" style="text-align: left;">The initial target for buyers is the pre-market high set at $3.39.</p>
<p class="paragraph" style="text-align: left;">Further upside targets include $4, $5, $5.50, $6, and $6.86.</p>
<p class="paragraph" style="text-align: left;">Should it dip below $3.39, downside targets are $3, $2.80, $2.60, $2.46, $2.20, $2, $1.80, $1.47, followed by a gap fill at $1.13.</p>
<hr class="content_break"/>
<p class="paragraph" style="text-align: left;"><b>STEM – Increased over 11% in pre-market after announcing its support for a 484 MW Hungarian solar portfolio, marking a major software deal in EMEA.</b></p>
<p class="paragraph" style="text-align: left;">Stem, Inc. (<b>STEM</b>) provides a digitally connected, intelligent renewable energy storage network globally.</p>
<p class="paragraph" style="text-align: left;">This morning, the company revealed that its award-winning solar monitoring and optimization tools will be standard for the commercial operation of a 484 MW solar portfolio for Neovolt, one of Hungary’s largest asset managers.</p>
<p class="paragraph" style="text-align: left;">Under a five-year contract, Stem’s PowerTrack Web will oversee, optimize, and control eight utility-scale sites in Hungary, providing a comprehensive view across the entire portfolio.</p>
<p class="paragraph" style="text-align: left;">SHares of <b>STEM</b> rose more than 11% in pre-market on the announcement.</p>
<div class="image"><img decoding="async" class="image__image" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXfo07WhOZ5QC5Rbn2xVV9mPdLDnoayev_hPEKVcgzk3rOHCfvvt_05Ze0aFRH1ypRRctoVlYfr0vdFfZZy5O9xQQrYHHKpoLF5QrVDjdazkpHwyLrimRzvRFJK6xT6962VJRc30Gw?key=b78cVTfpYS4IEGNeHPhO1T7s" alt=""/></div>
<p class="paragraph" style="text-align: left;">The $0.73 region proved supportive in pre-market trading and remains a key level to observe.</p>
<p class="paragraph" style="text-align: left;">Should it surpass this level, potential resistance points include $0.76, $0.80, $0.8315, and then the pre-market high at $0.8590. Beyond those, further targets include $0.92, $1, $1.13, $1.20, $1.35, $1.50, and $1.68.</p>
<p class="paragraph" style="text-align: left;">Conversely, should it drop below $0.73, downside targets include $0.70, $0.67, and $0.57, with $0.50 as a further support level.</p>
<hr class="content_break"/>
<div class="section" style="background-color: #efefef; margin: 0; padding: 0;">
<h5 class="heading" style="text-align: center;">*Sponsored by 1440 Media</h5>
<h3 id="looking-for-unbiased-factbased-news" class="heading" style="text-align: left;">Seeking unbiased, factual news? Join 1440 today.</h3>
<div class="image"><img decoding="async" class="image__image" style="border-radius: 0; border: 0; solid #E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/fa74d669-e47e-4540-84f0-1a0f3ed64b89/1aae14d18ebe7ada398a3688410a72a3.png?t=1715814737" alt=""/></div>
<p class="paragraph" style="text-align: left;">Enhance your news consumption with 1440! Our daily newsletter, trusted by millions, delivers a concise, 5-minute overview of global events. We sift through over 100 sources to provide fact-based news related to politics, business, and culture—free of any bias.</p>
<p class="paragraph" style="text-align: left;">Sign up for 1440 today.</p>
</div>
<hr class="content_break"/>
<p class="paragraph" style="text-align: left;"><b>RGNX – Up over 18% in pre-market after announcing an exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases.</b></p>
<p class="paragraph" style="text-align: left;">REGENXBIO Inc. (<b>RGNX</b>) is a clinical-stage biotech firm focused on providing gene therapies targeting genetic defects in the U.S.</p>
<p class="paragraph" style="text-align: left;">This morning in pre-market trading, the company announced a strategic partnership aimed at the development and commercialization of RGX-121 for treating Mucopolysaccharidosis II (MPS II), known as Hunter syndrome, and RGX-111 for Mucopolysaccharidosis I (MPS I), known as Hurler syndrome.</p>
<p class="paragraph" style="text-align: left;">Under the agreement, REGENXBIO will receive $110 million at the closing of the deal and potentially up to an additional $700 million upon achieving various milestones—$40 million related to development and regulatory milestones, and $660 million relating to sales milestones. Additionally, REGENXBIO will earn significant double-digit royalties on net sales in the U.S. and Asia.</p>
<p class="paragraph" style="text-align: left;">As of yesterday’s closing, <span style="color: #232a31;">RGNX had a market cap of $344.34 million</span>, based on Finviz data.</p>
<p class="paragraph" style="text-align: left;">Shares of <b>RGNX</b> are currently up over 18% in pre-market trading following this announcement.</p>
<div class="image"><img decoding="async" class="image__image" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXe5n9DMEpsefAP6ZZSwLFpFG8z7xrz8N9ji0m-903Lws1MRtCL7U7Z72vs0Yk3NhTNvOZ_q3Vq0jI1Jr_OROAUulHR6EuBC5XrheF-8n3JgcY-OOGn0Z3bNaWBL2s_0KSqhtlPA?key=b78cVTfpYS4IEGNeHPhO1T7s" alt=""/></div>
<p class="paragraph" style="text-align: left;"><span style="color: #232a31;">The $7.25 level has proven to be a support area in pre-market and is crucial to monitor.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #232a31;">If it breaks above $7.25, watch for targets at $7.65, $8, $8.35, $8.60, $8.70, $8.80, and the pre-market high of $8.93. Beyond these, targets could reach $9.30 and $10.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #232a31;">If it falls below $7.25, look for support at $7, $6.95, $6.80, and then $6.56.</span></p>
<hr class="content_break"/>
<p class="paragraph" style="text-align: center;"><span style="font-size: 1.5rem;"><b>MARKET NEWS </b></span>📰</p>
<div class="image"><img decoding="async" class="image__image" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcXep5ZdigBNAcsoMS1m5OVOXwILdxgPk9fDPz6v8r-Bo_rw-_1kgWySs3sa1OgB3uaIAWj7amBpj9USWvczDnHtQr7wPHEapVsT8lhTurQZ1TvVIlzftV5f8AtbYgp61VINHKPRg?key=b78cVTfpYS4IEGNeHPhO1T7s" alt=""/></div>
<hr class="content_break"/>
<div class="section" style="background-color: #efefef; margin: 0; padding: 0;">
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>DISCLAIMER</b></span><span style="color: #868686; font-size: 0.8rem;">: To fully understand any services provided by Ragingbull.com, LLC (“RagingBull”), please review our complete disclaimer located at </span><span style="color: #868686; font-size: 0.8rem;"><span style="text-decoration: underline;">https://ragingbull.com/disclaimer</span></span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE.</b></span><span style="color: #868686; font-size: 0.8rem;"> Any services offered by RagingBull are solely for educational and informational purposes and should NOT be regarded as a securities-related offer or solicitation and should not be relied on as personalized investment advice. RagingBull recommends consulting a licensed professional before making any investment choices.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>RESULTS PRESENTED NOT TYPICAL OR VERIFIED.</b></span><span style="color: #868686; font-size: 0.8rem;"> RagingBull's services may provide information regarding the historical performance of RagingBull owners or employees and/or testimonials from non-employees indicating profitability that are believed to be accurate based on the representations from the persons providing testimonials. However, subscriber trading results have NOT been tracked or verified, and past performance is not an indicator of future results. The results presented in this communication are NOT TYPICAL. Actual results can vary widely depending on various factors such as experience, skill, risk management practices, market dynamics, and the capital used. Investing in securities is speculative and contains high risks; you might lose some, all, or potentially more than your initial investment.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER.</b></span><span style="color: #868686; font-size: 0.8rem;"> RagingBull and its owners or employees are not registered as securities broker-dealers, brokers, investment advisors (IA), or IA representatives with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of RagingBull.com are compensated fully or partially by commissions based on their sales of services to subscribers.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>RagingBull.com, LLC is entitled to recover attorneys’ fees, costs, and expenses.</b></span><span style="color: #868686; font-size: 0.8rem;"> If any legal action is taken concerning business dealings with RagingBull.com, LLC and/or its affiliates or if any legal action is needed to enforce these Terms of Service, RagingBull.com, LLC is entitled to recover attorneys’ fees, costs, and expenses in addition to any other relief it may be eligible for.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>*Sponsored Content:</b></span><span style="color: #868686; font-size: 0.8rem;"> If you purchase anything from a link in this email (excluding RagingBull services), assume an affiliate relationship exists with the company providing the product or service you bought, and we may receive compensation. We recommend conducting your research before making any purchases. While we believe in the companies we form affiliate relationships with, please ensure that you genuinely believe these products or services will help you achieve your goals before spending any money.</span></p>
<p class="paragraph" style="text-align: left;"><span style="color: #868686; font-size: 0.8rem;"><b>WE MAY HOLD SECURITIES DISCUSSED.</b></span><span style="color: #868686; font-size: 0.8rem;"> RagingBull has not received direct or indirect payment from any security issuer mentioned in our services, except potentially from advertisers in this email. Nonetheless, RagingBull.com, LLC, its owners, and its employees may buy, sell, or maintain long or short positions in the securities of the companies referred to in this communication.</span></p>
</div>
</div>
<script type="text/plain" data-cli-class="cli-blocker-script" data-cli-script-type="analytics" data-cli-block="true" data-cli-element-position="head">
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,'script','https://connect.facebook.net/en_US/fbevents.js?v=next');
</script>This retains the core details and intent of the original content, while altering the phrasing for originality.
